AU2091370A - Improvements; in virus vaccines - Google Patents
Improvements; in virus vaccinesInfo
- Publication number
- AU2091370A AU2091370A AU20913/70A AU2091370A AU2091370A AU 2091370 A AU2091370 A AU 2091370A AU 20913/70 A AU20913/70 A AU 20913/70A AU 2091370 A AU2091370 A AU 2091370A AU 2091370 A AU2091370 A AU 2091370A
- Authority
- AU
- Australia
- Prior art keywords
- virus vaccines
- vaccines
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU20913/70A AU456693B2 (en) | 1970-10-09 | 1970-10-09 | Improvements; in virus vaccines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU20913/70A AU456693B2 (en) | 1970-10-09 | 1970-10-09 | Improvements; in virus vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2091370A true AU2091370A (en) | 1972-04-13 |
| AU456693B2 AU456693B2 (en) | 1974-12-09 |
Family
ID=3710203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU20913/70A Expired AU456693B2 (en) | 1970-10-09 | 1970-10-09 | Improvements; in virus vaccines |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU456693B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2483780A1 (en) * | 1980-06-06 | 1981-12-11 | Bellon Labor Sa Roger | Living vaccine against sheep and goat echtyma - cultured from an avirulent strain and administered subcutaneously or intra-dermally |
| FR2499411A1 (en) * | 1981-02-09 | 1982-08-13 | Inst Biokhim Fiziol | Live vaccine against contagious ecthyma of sheep - prepd. from virus attenuated by passaging on foetal skin cells |
-
1970
- 1970-10-09 AU AU20913/70A patent/AU456693B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU456693B2 (en) | 1974-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA950358A (en) | Vaccines | |
| AU456693B2 (en) | Improvements; in virus vaccines | |
| AU473436B2 (en) | Stable virus preparations | |
| AU451635B2 (en) | Vaccine preparation | |
| CA957279A (en) | Vaccine preparation | |
| AU2788871A (en) | Varicella vaccine | |
| CA817394A (en) | Vaccines | |
| AU2091470A (en) | Improvements in virus vaccine applicators | |
| CA857299A (en) | Vaccines | |
| CA853671A (en) | Vaccines | |
| CA839228A (en) | Vaccine and its preparation | |
| AU432686B2 (en) | Vaccines | |
| CA814977A (en) | Vaccines | |
| CA838085A (en) | Vaccines comprising water-in-oil solutions | |
| AU440195B2 (en) | Vaccine preparation | |
| AU443666B2 (en) | Virus composition | |
| ZA716689B (en) | Stable virus preparations | |
| AU6270269A (en) | Vaccines | |
| AU424740B2 (en) | Vaccines | |
| CA830964A (en) | Equine encephalomyelitis vaccine | |
| CA916592A (en) | Viral vaccines | |
| AU1683070A (en) | Vaccine preparation | |
| AU434914B2 (en) | Improvements in air-break-switches | |
| AU463131B2 (en) | Improvements in hosepipes | |
| AU468826B2 (en) | Improvements in hosepipes |